Using Glycated Albumin and Stimulated C-Peptide to Define Partial Remission in Type 1 Diabetes

Overview of attention for article published in Frontiers in endocrinology, July 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 5 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 35,459 followers.

RT @FrontEndocrinol: New Research: Using Glycated Albumin and Stimulated C-Peptide to Define Partial Remission in Type 1 Diabetes: Objectiv…

19 Jul 2022

Reply Repost Favourite

RT @FrontEndocrinol: New Research: Using Glycated Albumin and Stimulated C-Peptide to Define Partial Remission in Type 1 Diabetes: Objectiv…

19 Jul 2022

Reply Repost Favourite

New Research: Using Glycated Albumin and Stimulated C-Peptide to Define Partial Remission in Type 1 Diabetes: Objective To propose a new definition of partial remission (PR) for patients with type 1 diabetes (T1D) of all-ages using… https://t.co/Vlk701c42

19 Jul 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.